The pivotal Phase 2 trial (NCT04881760), published in The New England Journal of Medicine (Jastreboff et al., 2023), enrolled 338 adults with BMI 30 or higher
research compound only Product Specifications Format: lyophilized powder in vial (reconstitute with bacteriostatic water) Strengths available: 10 mg per vial
If the mouse figure of 3.5% oral bioavailability holds in humans, 100 mg swallowed delivers roughly 3.5 mg systemically, which is why 100 mg oral and 5 mg subcutaneous end up as the two standard protocols
PMID: 21795440
Ideal for dogs with low energy, appetite issues, or specific health conditions, our liquid B12 is bioactive and ready for immediate use
Most clients benefit from weekly or biweekly treatments, depending on their goals and how they feel